Late Clonal Complications in Older Patients Receiving Immunosuppressive Therapy for Aplastic Anemia
Authors: André Tichelli, Michel Henry-Amar, None Gérard Socié
Journal: Annals of Internal Medicine (1999)

Letters19 October 1999Late Clonal Complications in Older Patients Receiving Immunosuppressive Therapy for Aplastic AnemiaAndré Tichelli, MD, Michel Henry-Amar, MD, and Gérard Socié, MDAndré Tichelli, MDDr. Tichelli: Kantonsspital Basel; CH-4031 Basel, SwitzerlandDr. Henry-Amar: Centre François Baclesse; F-14076 Caen Cedex 5, FranceDr. Soci: Hôpital St. Louis; 75475 Paris Cedex 10, FranceSearch for more papers by this author, Michel Henry-Amar, MDDr. Tichelli: Kantonsspital Basel; CH-4031 Basel, SwitzerlandDr. Henry-Amar: Centre François Baclesse; F-14076 Caen Cedex 5, FranceDr. Soci: Hôpital St. Louis; 75475 Paris Cedex 10, FranceSearch for more papers by this author, and Gérard Socié, MDDr. Tichelli: Kantonsspital Basel; CH-4031 Basel, SwitzerlandDr. Henry-Amar: Centre François Baclesse; F-14076 Caen Cedex 5, FranceDr. Soci: Hôpital St. Louis; 75475 Paris Cedex 10, FranceSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-8-199910190-00030 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We agree with Kami and colleagues that the incidence of malignant hematologic conditions was lower in patients 60 years of age or older than in patients age 20 to 49 years or patients age 50 to 59 years. However, we think that it is more appropriate to present these results by using a time-dependent method. The probability of developing a malignant hematologic disorder at 10 years was 12% ± 3% in patients age 20 to 49 years, 17% ± 6% in patients age 50 to 59 years, and 5% ± 3% in patients age 60 years or older. ...Reference1. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al . Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152-7. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: André Tichelli, MD; Michel Henry-Amar, MD; Gérard Socié, MDAffiliations: Dr. Tichelli: Kantonsspital Basel; CH-4031 Basel, SwitzerlandDr. Henry-Amar: Centre François Baclesse; F-14076 Caen Cedex 5, FranceDr. Soci: Hôpital St. Louis; 75475 Paris Cedex 10, France PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoEffectiveness of Immunosuppressive Therapy in Older Patients with Aplastic Anemia André Tichelli , Gérard Socié , Michel Henry-Amar , Judith Marsh , Jakob Passweg , Hubert Schrezenmeier , Shaun McCann , Jill Hows , Per Ljungman , Pedro Marin , Aruna Raghavachar , Anna Locasciulli , Alois Gratwohl , and Andrea Bacigalupo , for the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party Metrics 19 October 1999Volume 131, Issue 8 Page: 633-634 Keywords Age groups Aplastic anemia Immunosuppressives ePublished: 15 August 2000 Issue Published: 19 October 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...